All Episodes

Building Precision NanoSystems and the Road to a Danaher Exit

From PhD to Public Company: Jason Kelly on Building Ginkgo and What Comes Next

The Biotech IPO: What Bankers See That Founders Miss

From Bench to Boardroom: What Drug Development Actually Takes